David Stamler
Vorstandsvorsitzender bei ALTERITY THERAPEUTICS LIMITED
Aktive Positionen von David Stamler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALTERITY THERAPEUTICS LIMITED | Vorstandsvorsitzender | 07.01.2021 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.05.2017 | 07.01.2021 |
Karriereverlauf von David Stamler
Ehemalige bekannte Positionen von David Stamler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.01.2015 | 01.01.2017 |
AUSPEX PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 | 05.05.2015 |
XENOPORT, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2008 | 19.11.2010 |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 | 01.01.2008 |
Fujisawa Pharmaceutical Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP | Corporate Officer/Principal | 01.01.2003 | 01.01.2005 |
Fujisawa Healthcare, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 | 01.01.2005 |
Astellas Research Institute of America LLC | Corporate Officer/Principal | 01.01.2000 | 01.01.2003 |
ABBOTT LABORATORIES | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1993 | 01.01.1997 |
Ausbildung von David Stamler
The University of Chicago | Undergraduate Degree |
Pritzker School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Israel | 2 |
Japan | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 6 |
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 8 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ABBOTT LABORATORIES | Health Technology |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
ALTERITY THERAPEUTICS LIMITED | Health Technology |
Private Unternehmen | 6 |
---|---|
Fujisawa Pharmaceutical Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP | Health Technology |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Health Technology |
XenoPort, Inc.
XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
Fujisawa Healthcare, Inc. | |
Astellas Research Institute of America LLC | |
Auspex Pharmaceuticals, Inc.
Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- David Stamler
- Erfahrung